Exploring Short-Term Responses to Changes in the Control Strategy for Chlamydia trachomatis

Table 2

Annual costs of screening and partner notification (PN) when screening coverage is increased to 25% and tracing efficiency to 40%. Costs are shown for one year and three years after the change. The first row shows the case at the 8% baseline steady state.

—	Annual cost of screening (£)	Annual cost of PN (£)	Total annual cost (£)	Cost per infection treated (£)	Prevalence (%)
Baseline	42,951,600	4,319,000	47,270,600	633.26	8
Tracing efficiency to 40%—1 year	42,951,600	5,387,140	48,338,740	660.92	7
Tracing efficiency to 40%—3 years	42,951,600	4,086,796	47,038,396	847.77	5.3
Screening coverage to 25%—1 year	67,111,875	6,421,901	73,533,776	665.89	7.3
Screening coverage to 25%—3 years	67,111,875	5,442,289	72,554,164	775.29	6.3